Clinical Predictors of Outcome in Adult Patients with Acute Leukemias and Myelodysplastic Syndrome and COVID-19 Infection: Report from the American Society of Hematology Research Collaborative (ASH RC) Data Hub
Desai P, Goldberg A, Anderson K, Narendra V, Neuberg D, Radhakrishnan V, Redd R, Roboz G, Sehn L, Sekeres M, Stahl M, Tallman M, Thompson J, Tucker E, Wood W, Hicks L. Clinical Predictors of Outcome in Adult Patients with Acute Leukemias and Myelodysplastic Syndrome and COVID-19 Infection: Report from the American Society of Hematology Research Collaborative (ASH RC) Data Hub. Blood 2021, 138: 280. PMCID: PMC8701680, DOI: 10.1182/blood-2021-146016.Peer-Reviewed Original ResearchAcute myeloid leukemiaAcute lymphocytic leukemiaEntity's Board of DirectorsMyelodysplastic syndromeTime of COVID-19 diagnosisCurrent equity holderActive diseaseBoard of directorsCOVID-19 severityCOVID-19 infectionCOVID-19 registryICU careCOVID-19 diagnosisHematologic malignanciesBristol Myers SquibbPublicly-traded companiesResponse groupMultivariate analysisPredictors of severe infectionTypes of hematological malignanciesHospitalized patientsAssociated with advanced ageAssociated with neutropeniaAssociated with increased mortalitySevere COVID-19 infection
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply